Dr. Reddy's to acquire Haleon's nicotine replacement biz for 500 mn pounds

Quick Summary:

Reddy's will acquire the NRT business in all countries outside of the United States.

The portfolio is attractive for its customer loyalty, its global nature, and the access it provides to key customers.

The Nicotinell portfolio spans over 30 countries across Europe, Asia (including Japan), and Latin America.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaIsraelJapanUnited States

Topics: Dr. Reddy's Laboratories OTC brands NRT acquisition Nicotine replacement therapy Consumer healthcare Global pharma company. Haleon Erez Israeli Nicotinell

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-06-26 @ 19:54:15 (6 days ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 354 words

Reading Time: 2 minutes read

Sentences: 20 lines

Sentence Length: 18 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 21394444

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 237 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions